我的持仓大概情况

My approximate overview of my holdings

My holdings: Tongce Medical, Huaxia Eye Hospital, Pharmaceutical ETF, NASDAQ ETF, Robotics ETF, Battery ETF, Coal ETF, China Coal Energy, Longi Green Energy (preparing to sell), Salt Lake Shares, Wuliangye, Zhongju High-tech, Zhejiang Dingli, Fara Electronic, Hongyuan Electronics, Ganfeng Lithium, Securities ETF, Silan Micro, Mindray Medical, Luzhou Laojiao, Aima Technology.

Today the market plummeted, many people are very worried. Good companies, not expensive prices. I’m not afraid of declines; opportunities are created by drops, risks are created by rises. I believe there’s nothing to worry about. All the stocks I bought are bottom-position stocks with strong resilience and rebound capabilities.

Among my holdings, Zhongju High-tech has no hot topics and is unlikely to hit new lows. I feel it’s safe. Zhongju High-tech’s capacity will reach 950,000 tons after technological upgrades, an increase of 200,000 tons. The company used to focus on food factories and restaurants, but is now gradually entering household use and supermarket collaborations. These capacities can be fully absorbed without mergers. The current valuation of the company is very promising, so even if there’s no growth, it can still profit from valuation fluctuations.

Salt Lake Shares, with a conservative estimate of 10 billion yuan net profit in 2026. Currently at 172.1 billion yuan market cap, with a PE ratio of 17. I think it’s not only cheap but also a big opportunity.

Ganfeng Lithium, a leading lithium mining company, will see a major breakout in 2026 and 2027. Central government documents require lithium battery pollution charges to be levied on producers, starting in 2027. This will put significant pressure on downstream companies. They can either outsource lithium battery recycling to Greenmei or build their own recycling systems like Salt Lake, Ganfeng, Tinci, and CATL. Building recycling systems is very challenging, as it requires setting up facilities in every city, only feasible for top-tier companies, which gives them a clear advantage.

Hongyuan Electronics is experiencing volume and price increases, with chips being heavily replaced at the bottom. It’s about to enter an upward channel, and I feel very secure. The company has excellent quality, low debt, high gross margin, and high net profit.

Wuliangye, I see this as a stock I will hold for a lifetime. I mentioned yesterday that brand value will restore its net profit. Overall, the company is just a bit slow; in the next 5 to 8 years, it’s highly probable to return to 350 yuan. This is a likely profit opportunity.

Huaxia Eye Hospital, Xiamen Eye Center Hospital, a company that sustains the entire business. The other 26 hospitals are now supporting it, like raising children. As long as one succeeds, it adds to the company’s strength. The current price is low and unlikely to fall much further. Even if the market drops below 3800 points, I won’t feel much pressure.

Zhejiang Dingli, with rapid growth but stagnant stock price, will eventually catch up. Doubling my returns is just a matter of time, so I’m not worried about the market continuing to decline.

Fara Electronic has basically completed its bottoming process. The company has high gross margin, high net profit margin, and industry-specific barriers. It’s also low-priced. Doubling in three to five years is very feasible, so I see no major issues.

Silan Micro has solid fundamentals now. The new 20 billion yuan chip project in Xiamen will start in 2028. The chip industry is currently in a supply shortage. The company’s growth is very certain. As long as initial investments and depreciation are accounted for, future growth will be strong. After overcoming the investment phase, growth will be continuous, similar to SMIC. The stock price was stagnant for years due to high equipment costs and depreciation, but once growth explodes, it will be very powerful.

Mindray Medical, whether in terms of technological barriers, product quality and price, or current stock price, is at an attractive level. The company’s medical devices are gradually replacing low- and mid-end products overseas and moving toward high-end markets, albeit slowly. It’s a company with unlimited potential. The market decline has little impact on it. Currently, top executives are increasing holdings at around 200 yuan, showing their confidence in the company’s future.

Luzhou Laojiao is the most resilient among the four major top-tier liquor companies (Maotai, Wuliangye, Luzhou Laojiao, Fenjiu). Its valuation is also very good. Today it showed its resilience. Although my position is somewhat large, I am not worried.

Aima Technology, whether electric scooters can grow in the future doesn’t affect its stock price rise. The valuation is already very low, and profits are well assured. The popularization of electric scooters is like the earlier motorcycle boom—an unstoppable dividend. This dividend will be realized sooner or later, so I will just hold it safely.

Good companies, as long as bought cheaply and without overheated consumption, I can earn some money between very cheap and cheap. If consumption heats up, I can profit from the difference between cheap and expensive. It’s a very profitable investment.

Overall, my cost basis is very low. Currently, Zhongju High-tech has the largest loss at 13%. Others are only a few points in loss or profit, mostly relatively safe positions. They are resilient against market declines. All the stocks in my portfolio have growth points even if the market doesn’t rise. Beating the market in three to five years is almost certain. Every major pullback is an opportunity to add positions, not to escape.

The above are personal opinions, not necessarily correct, for reference only, and do not constitute any investment advice.